Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/20/2025

Interpretation of a Negative ANARFX8 Result

Clinical Significance of Negative ANA Results

  • A negative ANA test significantly decreases the probability of systemic autoimmune diseases such as systemic lupus erythematosus (SLE), Sjögren's syndrome, systemic sclerosis, and mixed connective tissue disease 1, 3
  • The absence of detectable ANA suggests that the patient is unlikely to have a systemic autoimmune rheumatic disease (SARD), as these antibodies are present in most cases of autoimmune connective tissue diseases 2, 3
  • A negative result has a high negative predictive value for excluding SLE in particular, as ANA is positive in approximately 95-98% of SLE cases 3

Understanding the ANARFX8 Test

  • The reference method for ANA detection is indirect immunofluorescence assay (IIFA) on HEp-2 cells, which has high sensitivity (95.8%) 1, 2

Important Caveats and Considerations

  • Despite a negative ANA result, if clinical suspicion for an autoimmune disease remains high, specific antibody testing should still be considered 2, 3
  • False negative results can occur with automated methods, which is why IIFA remains the reference standard 2, 3

When to Consider Further Testing Despite Negative ANA

  • If there are strong clinical features suggestive of a specific autoimmune disease 2, 3
  • When specific autoantibodies not detected by standard ANA testing are suspected (e.g., anti-neutrophil cytoplasmic antibodies for vasculitis) 5, 6

Follow-up Recommendations

  • If symptoms persist or evolve, consider targeted testing for specific autoantibodies based on clinical presentation, regardless of the negative ANA result 2, 3